chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient developed fever up to 101-1-02 degrees F 6 days after the vaccine. Then developed a rash on the legs, arms and face. Fever subsided to low grade about 99 degrees F.
Severe pain when injecting, pain has continued for 3 weeks and transverse to hand.
10 minutes after receiving the vaccine, I felt dizziness, light headedness, tightness in my chest, difficulty swallowing and I felt extreme pressure in my ears (as if I was underwater). I left the site and went to get something to drink, and found it slightly difficult to swallow. So, I started heading to Hospital to be seen but by the time I got to the hospital the dizziness and light headedness had resolved, and I was able to swallow. So, I decided to return back to work. 5 hours after vaccine I developed a severe shooting pain down my left arm and leg, which lasted through the night, and when I went to bed, I decided to lay on the side that was hurting. When I woke up the next morning, it had resolved. I still had pain at the injection site, but not the intense shooting pain from the night before. The chest pain/tightness and ear pressure lasted for about a week after the vaccine, then resolved.
One week prior to my second shot, I was diagnosed with an UTI.  Since my last was 2008 and nothing had changed except the first Covid shot, I thought it was note worthy.
UNSTABLE ANGINA ANGINA, UNSPECIFIED 1/29/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
body aches headaches fever of 101.2 fatigue tiredness tachycardia reached 152 leg pain light vaginal spotting (not near my expected period dates)
Patient was fine initially after vaccination at 430 PM, 15 minutes later as I was giving him his card he described suddenly feeling lightheaded and nauseous. I gave him some water and a Benadryl tab, within a minute he asked to go to my bathroom. He than began to vomit for a few minutes. By 5 PM he came to me, saying he felt better. I had him take a second Benadryl tablet, and he felt well enough to walk home.
My arm got red and blotchy. The spots puffed up a lot. Then my skin felt hot on the spots. Then it was extra sore and itchy. The spots got worse, and by day 5 my whole upper arm was red and super itchy and sore. My doctor prescribed a cream and told me it was an allergic reaction. He advised I do not get the vaccine again.
Chills, slight fever, intense headache, nausea - vomiting and dry heaves    Nausea treatment = pedialite freezer pops Nausea = 12 hours/  fever = 24 hours/ headache & chills = 36 hours
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration) on or about 18-APR-2014, by a physician, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 14-APR-2016, the patient was treated by a physician for a painful rash that was diagnosed as shingles. Again, on or about 12-OCT-2016, the patient was treated at the same facility for a severe outbreak of herpes zoster, a chronic and incurable condition, for which the patient was prescribed VALTREX to manage her symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Narrative: Received vaccine at outside facility. Per PCP note 2/24/22: "She had a reaction after receiving J&J covid-19 vaccine -flushing, lip swelling. She spoke to her immunologist about it. They don't think she is allergic to the excipient because same excipient is used for dupixant. So she may be allergic to the covid-19 viral particle."
Pt devel a flu-like illness including h/a following vax w/Hep B in 1987; No further details were provided;
Information has been received from a registered nurse concerning a patient with a history of pulmonary disease who was vaccinated with pneumococcal 23v polysaccharide vaccine (lot # 0650649/0790P). The registered nurse reported that the patient developed redness, swelling and heat in the injection site arm after vaccination, during the past 3 months. The patient received oral antibiotics. At the time of the report, it was unknown of the patient recovered. The registered nurse felt that redness, swelling and heat in the patient's injection site arm was considered to be disabling. It was also reported that two other patient's had similar experiences and were treated with oral antibiotics (WAES0510USA07487 and WAES0606USA04361). It was also reported that another patient had similar experiences and was treated with IV antibiotics (WAES0510USA08765). The registered nurse reported that three patient recovered and one patient did not recover. Additional information has been requested.
Arm and legs are shaking; Jerking; Joints are painful; joint pain especially in the finger; Feeling weird; This is a spontaneous report from a contactable consumer (patient's husband). An 81-year-old female patient received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9265), via an unspecified route of administration, on 27Jan2021 at 11:45, at a single dose, for COVID-19 immunization; and rosuvastatin, via an unspecified route of administration, in Feb2021 for 3 days, at an unspecified dose and frequency, for blood cholesterol. The patient's medical history included high blood pressure. The patient's concomitant medication included ongoing amlodipine for high blood pressure. The patient's husband was calling about the COVID-19 vaccine and he is not sure if what the patient was experiencing was because of the vaccine or a prescription drug (rosuvastatin) she took but her arm and legs are shaking like jerking and joints are painful on 04Feb2021. The medication the patient's husband was referring to is rosuvastatin which the patient takes for cholesterol. The patient took this for 3 days and she started feeling weird in Feb2021, so she stopped taking. The patient's husband not sure what to do since the patient went to the doctor and the doctor did not find anything, she went to the emergency room. The patient was hospitalized for two days. The patient also saw a specialist neurologist who recommended to take more tests, but the patient is waiting for the tests. In 2021, the patient had a magnetic resonance imaging (MRI) and electroencephalography (EEG). The patient was experiencing joint pain especially in the finger at night still (the joint pain is not in the arm and legs but in her finger). This started a few days later and was still going on. It has stayed the same and some days are better and then some days are worse. The patient was admitted to the hospital in 2021 for 2 days due to events. No treatment was received for the events. The action taken in response to the events for rosuvastatin was permanently withdrawn in Feb2021. The outcome of "Feeling weird" was unknown. The patient had not recovered from "Joints are painful; joint pain especially in the finger". The patient was recovering from the remaining events.
: 10 minutes after vaccination to left deltoid, patient approached medical assistant in observation area and reported left neck discomfort and difficulty breathing ?with mask on?; patient taken immediately to exam room for evaluation by nurse practitioner, including full set of vital signs and clinical eval (physical exam and subjective interview); performed continuous monitoring in exam room (including vital signs and physical exam) with 2nd nurse practitioner  joining at times to assist; after several minutes, patient reported vision problems at which point patient was placed in supine position on exam table; after laying supine for several minutes, patient exhibited seizure like activity; at onset of seizure activity, notified COVID-19 RN to activate EMS via 911; Epinephrine via autoinjector was then administered to left vastus lateralis; continued clinical evaluation and vital signs monitoring until EMS arrived at scene to assume care; patient alert and accompanied by staff for transport to Hospital via EMS
No additional AE; TE for VAXNEUVANCE/ and ROTATEQ/ which was also administered to a patient on 06/29/2023; This spontaneous report was received from the Medical Assistant, and refers to a 6-month-old female patient. Her medical history, concurrent conditions, and concomitant therapies were not provided.  On 29-JUN-2023, the patient was vaccinated with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, 0.5 milliliter, lot #W039033, expiration date: 01-OCT-2024, administered for prophylaxis (strength, and route of administration were not provided); and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milliliter, lot #1968385, expiration date: 22-MAY-2024, administered orally for prophylaxis (strength was not provided). The vaccines were improperly stored: pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) current excursion (49.1F) for 34 minutes; with two previous excursions at (35.9F) for 2 minutes and again at (35.9F) for 2 minutes), and rotavirus vaccine, live, oral, pentavalent (ROTATEQ): same excursion details (product storage error). No additional adverse event information was provided. ; Sender's Comments:  US-009507513-2307USA004472:
Information has been received from a licensed practical nurse concerning a 13 year old white male with no pertinent medical history and no known drug allergies who on 11Nov96 was vaccinated with a first dose of varicella virus vaccine live, SC in the left arm. On 04Nov2003 the pt presented to the Dr's office with break through chickenpox, described as a 24 hour rash with red vesicular lesions over his trunk,arms, and body. The pt also had a mild fever and a runny nose. Medical attention was sought. The child was prescribed desloratadine (Clarinex) for treatment as needed. There was no product quality complaint. The pt recovered. No further information is expected.
No other AE; expired doses of VAQTA; This spontaneous report was received from medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 17-JUN-2022, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5 milliliter, once, lot #T031201, expiration date: 14-JUN-2022 (expired product administered) (route of administration and injection site were not provided) for prophylaxis. Hepatitis a vaccine, inactivated (VAQTA) did not have any prior temperature excursions. Patient had no adverse effects or symptoms from this dose.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2206USA007065: US-009507513-2206USA007033: US-009507513-2206USA006941: US-009507513-2206USA006955: US-009507513-2206USA006951:
November 23?left hip sciatic pain mild to moderate. Took Tylenol and Advil throughout the day to relieve pain.   November 24?continued left hip sciatica, spreading down the front left thigh and groin area.   November 25?same and without Tylenol or Advil its aggravating. Still not a short acting pain but feels like a warning pain.   December 1?pain is diminishing and can sleep through the night without adjusting to avoid pinching the nerve. Still a deep tinge in my left hip area and leg   December 2?sciatic pain is likely and contained to the left side but there is now shingles like nerve pain but without a rash on both sides of my upper thighs. Hurts to touch and is a stinging-like pain. Pain relief from Advil lasted most of the day until bedtime.   December 6?the flareup on the right side is gone for a few days but the sciatic nerve pain continues on the left side whenever a sleep, wake up, put on socks and pants on the left foot and leg, and sitting for extended periods over 15 minutes.   December 8?same as last 2 days but with less intensity.  Fully resolved by 12/15/2021
Within minutes, pain, tingling, and numbness spread down my arm into my fingers, up into my neck, and into my back and shoulder blades. Over 3 hours later, fingers still feel cold and tingly, and my shoulder and elbow joints hurt deeply. I have limited movement of my left arm and shoulder. My neck is very stiff and sore.
This spontaneous report was received from a physician and a practice manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 10-FEB-2016, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 0.5 ml prefilled syringe (lot # L024132, expiration date: 21-JAN-2017; dose and route were not provided). The vaccine was exposed to following separate temperature excursion: first lasting for 488 hours, with the lowest recorded temperature of 34 degrees Fahrenheit and the second lasting for 32 hours, with the lowest recorded temperature of 32 degrees Fahrenheit. The vaccine was stored in a refrigerator. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Lips felt like being shocked - then labored breathing.  That resolved. Head felt like exploding within minutes of shot. That lasted into 2nd day. Lots of dizziness, nausea & headache into day 2
pt recvd vax & exp burning, stinging & local swelling; pt recovered; p/3rd inject pt exp same sxs again only more severe; pt recovered; pt found to be non-responder;
Patient stated they had red raised bumps that appeared 2 days after the vaccination. The bumps scabbed over and as of yesterday are finally disappearing.
skin sensitive to the touch; Body achiness; This is a spontaneous report from a contactable consumer. The consumer reported for a 19-year-old female patient who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EP6955) via an unspecified route of administration on 21Apr2021 at single dose for COVID-19 immunization. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number:unknown) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 22Apr2021, the reporters niece informed her that she was experiencing mild body achiness and mild skin sensitive to touch after receiving the second injection of the vaccine. Outcome was unknown for both the events.  No follow-up attempts are needed. No further information is expected.
Wrong formulation to 10 patients. Patients 6mo-5yo: they should have administered 2 doses of 0.25ml from the Dark Blue Cap and Label with Gray Border but instead they administered 2 doses of 0.2ml from the Dark Pink Cap and Label with Yellow Box.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Wrong formulation to 10 patients. Patients 6mo-5yo: they should have administered 2 doses of 0.25ml from the Dark Blue Cap and Label with Gray Border but instead they administered 2 doses of 0.2ml from the Dark Pink Cap and Label with Yellow Box.) and NO ADVERSE EVENT (No adverse event) in an infant patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Wrong formulation to 10 patients. Patients 6mo-5yo: they should have administered 2 doses of 0.25ml from the Dark Blue Cap and Label with Gray Border but instead they administered 2 doses of 0.2ml from the Dark Pink Cap and Label with Yellow Box.) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Wrong formulation to 10 patients. Patients 6mo-5yo: they should have administered 2 doses of 0.25ml from the Dark Blue Cap and Label with Gray Border but instead they administered 2 doses of 0.2ml from the Dark Pink Cap and Label with Yellow Box.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Wrong formulation to 10 patients. Patients 6mo-5yo: they should have administered 2 doses of 0.25ml from the Dark Blue Cap and Label with Gray Border but instead they administered 2 doses of 0.2ml from the Dark Pink Cap and Label with Yellow Box.).    No concomitant information was reported. Suspect product dosage text was reported as unknown. No treatment information was provided. This case is reported for patient 10 out of 10 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-731451 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-731451:Same reporter
Lots of hair coming off my head during and after showers starting in late April through the summer. I could tell by how thick my hair felt in a pony tail that it was thinner. I could tell by how long it takes to get wet and how I didn't get overheated as easily in the summer by my  hair. By August, I estimate 25-30% hair lost. No treatment. Outcome is the hair on my head is significantly thinner.
FATIGUE; RESTLESSNESS; TINGLING IN HANDS AND FINGERS; ITCHY RASH ON BOTH ARMS; This spontaneous report received from a patient concerned an 88 year old female. The patient's height, and weight were not reported. The patient's past medical history included heart surgery, and concurrent conditions included hypertension, and other pre-existing medical conditions included statins allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 180898, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced restlessness. On 09-APR-2021, the subject experienced tingling in hands and fingers. On 09-APR-2021, the subject experienced itchy rash on both arms. On 10-APR-2021, the subject experienced fatigue. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from restlessness, tingling in hands and fingers, and itchy rash on both arms on 10-APR-2021, and had not recovered from fatigue. This report was non-serious.
Very sore arm; Fever; Chills; Body aches; Sore joints; Nausea; Dose number: 3; This is a spontaneous report received from a non-contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 08Jan2022 at 09:45 (Lot number: unknown) at the age of 41 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Mitral valve prolapse" (unspecified if ongoing), notes: MVP; "Diabetes" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing); "polycystic ovarian syndrome" (unspecified if ongoing), notes: PCOS; "MTHFR deficiency" (unspecified if ongoing), notes: MTHFR and "Sulfonamide allergy" (unspecified if ongoing), notes: Known allergies: Sulfa. Concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: UNKNOWN, Route of administration: Unspecified), for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: UNKNOWN, Route of administration: Unspecified), for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 08Jan2022 at 09:45, outcome "unknown", described as "Dose number: 3"; PAIN IN EXTREMITY (non-serious) with onset 08Jan2022 at 10:00, outcome "unknown", described as "Very sore arm"; PYREXIA (non-serious) with onset 08Jan2022 at 10:00, outcome "unknown", described as "Fever"; CHILLS (non-serious) with onset 08Jan2022 at 10:00, outcome "unknown", described as "Chills"; PAIN (non-serious) with onset 08Jan2022 at 10:00, outcome "unknown", described as "Body aches"; ARTHRALGIA (non-serious) with onset 08Jan2022 at 10:00, outcome "unknown", described as "Sore joints"; NAUSEA (non-serious) with onset 08Jan2022 at 10:00, outcome "unknown", described as "Nausea". Therapeutic measures were not taken as a result of pain in extremity, pyrexia, chills, pain, arthralgia and nausea.  Additional information: The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient received one dose of Moderna vaccine following receiving Johnson and Johnson vaccine  on 4/7/21
Itchy Sensation all Over Bod; Redness and numbness of face; Numbness of face; A spontaneous report (United States) was received from a Healthcare Professional concerning a 42-years-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced itchy sensation all over body/pruritus, redness/erythema and numbness of face/hypoaesthesia.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 25 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 042L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 25 Jan 2021, the patient reported she experienced an itchy sensation all over her body, redness and numbness in her face. She self treated with diphenhydramine. All events seemed to have resolved on 27 Jan 2021.   Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events, itchy sensation all over body/pruritus, redness/erythema and numbness of face/hypoaesthesia, were considered resolved on 27 Jan 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.